Ondansetron Tablet, Orally Disintegrating
Product Images NDC 43063-857

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 43063-857). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063857)

This is a medication called Ondansetron which comes in tablet form with each tablet containing 4mg of the orally disintegrating drug. The recommended dosage is to take it 2 times a day and any side effects should be reported to the FDA. People who experience any side effects should call a doctor for medical advice. There is also a warning that it should be kept out of reach of children. The package insert includes reorder numbers, lot numbers and an expiration date of 02/2024.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.